News articles about VWR (NASDAQ:VWR) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. VWR earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned news coverage about the medical research company an impact score of 46.6132514235165 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

VWR has been the subject of several analyst reports. Zacks Investment Research downgraded VWR from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. ValuEngine downgraded VWR from a “buy” rating to a “hold” rating in a research report on Wednesday, October 11th. Finally, BidaskClub downgraded VWR from a “sell” rating to a “strong sell” rating in a research report on Friday, October 13th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. VWR presently has an average rating of “Hold” and an average price target of $31.67.

Shares of VWR (VWR) remained flat at $$33.25 during midday trading on Monday. The stock had a trading volume of 2,797,900 shares, compared to its average volume of 983,321. VWR has a 12 month low of $24.42 and a 12 month high of $37.25. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.25 and a quick ratio of 0.79. The company has a market cap of $4,380.00 and a PE ratio of 29.17.

VWR (NASDAQ:VWR) last released its quarterly earnings results on Tuesday, November 7th. The medical research company reported $0.54 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.46 by $0.08. VWR had a return on equity of 11.79% and a net margin of 4.11%. The business had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.16 billion. During the same quarter in the previous year, the firm posted $0.44 earnings per share. The company’s revenue was up 5.2% compared to the same quarter last year. equities research analysts anticipate that VWR will post 1.85 earnings per share for the current year.

WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/01/08/vwr-vwr-receiving-somewhat-favorable-press-coverage-analysis-shows.html.

About VWR

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Insider Buying and Selling by Quarter for VWR (NASDAQ:VWR)

Receive News & Ratings for VWR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR and related companies with MarketBeat.com's FREE daily email newsletter.